Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Executive Officer

Chief Technology Officer

Chief Business Officer

Executive VP, Research

Chief Medical Officer

EVP, Research

Sr. VP, Technical Development

Sr. VP, Research

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers bas...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-21	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-08-16	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-07-11	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-07-07	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-07-05	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-07-03	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-06-30	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Technology Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	Executive VP, Research
2022-02-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-12-21	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-12-21	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2021-04-21	Premium	sold	Premium	Premium	Premium	-
2021-03-29	Premium	sold	Premium	Premium	Premium	-
2021-03-26	Premium	sold	Premium	Premium	Premium	-
2021-03-25	Premium	sold	Premium	Premium	Premium	-
2021-03-24	Premium	sold	Premium	Premium	Premium	-
2021-03-23	Premium	sold	Premium	Premium	Premium	-
2021-03-22	Premium	sold	Premium	Premium	Premium	-
2021-03-19	Premium	sold	Premium	Premium	Premium	-
2020-12-17	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2020-12-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer

HOOK - Hookipa Pharma Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for HOOK